Kyle Greenway

Dr. Greenway is an Assistant Professor, a staff psychiatrist at the Jewish General Hospital, and an investigator at the Lady Davis Institute. He directs the Jewish General Hospital’s ketamine-assisted therapy program and co-leads a research laboratory in focused on psychedelic agents, pharmacology, and psychotherapy.

He pursued a research fellowship at the Psychedelic Research Centre at Imperial College, UK, and completed residencies in Psychiatry and the Clinical Investigator Program. Before his medical degree at McMaster University, he completed a Master’s degree in chemistry/physics at Simon Fraser University. He previously served as the assistant chief resident at the Jewish General Hospital in psychiatry and as the 2014 McMaster medical student president.